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j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe communicating junctions, composition, structure and characteristicsIn multicellular organisms, all cells need to communicate and have
evolved different mechanisms of intercellular communication, the
most direct and quickest of which is through channels that directly
link the cytoplasms of adjacent cells. Individual cells of metazoans
are interconnected by channels which span the two plasma mem-
branes and the intercellular space and result from the docking of
two hemichannels. These densely packed channels, localised in gap
junctions, allow cells to directly exchange ions and small molecules.
Hemichannels are hexameric torus of junctional proteins around an
aqueous pore. Vertebrates express two families of gap junction pro-
teins: the well characterized connexins and the more recently discov-
ered pannexins, the latter being related to invertebrate innexins
(“invertebrate connexins”). Some gap junctional hemichannels also
appear to mediate cell-extracellular communication. The present
issue of Biochimica et Biophysica Acta “Biomembranes” presents an
overview of the composition, structure and main characteristics of
the communicating junctions and will be completed by the compan-
ion issue entitled “The Communicating junctions, roles and dysfunc-
tions”, in preparation.
Gap junction channels arrange into densely packed clusters in spe-
cialized domains of the plasma membrane, forming two dimensional
sheets, termed gap junction plaques. The oligomeric assembly of
junctional proteins contains an aqueous pore crossing the plasma
membrane, and they use “gating” mechanisms to open and close
this pore in response to biological stimuli (e.g. a change in the trans-
membrane voltage). Channel proteins, like many other proteins, in-
deed possess moving parts able to perform such function. In the
presentation of the structural organization of intercellular channels,
Bargiello, Tang, Oh and Kwon [1] provide an up-to-date overview of
voltage-dependent conformational changes in the pore-forming re-
gion of connexin channels, primarily in terms of insights gained
from the crystal structure and molecular dynamics simulations. Two
distinct voltage-gating mechanisms (respectively a fast-gating and a
loop- or slow-gating) appear to be involved in conformational
changes.
Gap junctional polypeptides span the plasma membrane four
times and have both N and C-termini (NT and CT) intracellular.
Beyer, Lipkind, Kyle and Berthoud [2] present the sequence, function-
al roles, and structure of the NT domain of connexins, consisting of
their ﬁrst 22–23 amino acids. Although multiple connexin domains
contribute to the biophysical properties of gap junction channels
and hemichannels, several of the amino acids within the NT have im-
portant roles in voltage-dependent gating, unitary conductance, and
permeability. NT amino acids may also be involved in the modulation
of channel activity by some cytoplasmic components. NT or at least
parts of NT might also be required for proper trafﬁcking and forma-
tion of gap junction plaques.0005-2736/$ – see front matter © 2012 Published by Elsevier B.V.
doi:10.1016/j.bbamem.2012.05.008In contrast with the short NT regions, the CT domains differ mark-
edly both in length and in sequence among the connexins. This do-
main is well known to house a series of functionally important sites,
notably those for phosphorylation (a process implicated in diverse
roles including trafﬁcking of connexins to the plasma membrane
and assembly and degradation of the gap junction plaque) and for in-
teractions with cytoplasmic protein partners. Palatinus, Rhett and
Gourdie [3] provide a perspective on regulation of gap junction
plaque size and localization in the plasma membrane of ventricular
working myocardial cells, with a particular emphasis on the role of
the Connexin 43 CT.
Gap junctional proteins, as many other integral transmembrane
proteins, interact directly with a wide range of intracellular protein
partners in a dynamic and isoform-dependent manner to form mul-
tiprotein complexes, where pore-forming subunits bind to auxiliary
proteins (e.g. scaffolding proteins), which play essential roles in chan-
nel localisation and activity, thereby linking signalling enzymes, sub-
strates and effectors into a complex anchored to the cytoskeleton.
Hervé, Derangeon, Sarrouilhe, Giepmans and Bourmeyster [4] sum-
marise the data present in the literature regarding the proteins capa-
ble of interacting with junctional proteins and highlight the functions
of these protein–protein interactions in cell physiology and aberrant
functions in diseases.
As many other types of membrane channels, gap junctional chan-
nels localize to cholesterol and sphingolipid-enriched regions of the
plasma membrane known as lipid microdomains or “rafts”. The pre-
cise physiological roles of these lipid microenvironments still remain
elusive but increasing evidence suggests that they regulate the activ-
ity of channels through direct protein–lipid interactions and/or by
inﬂuencing the physical properties of the bilayer. Defamie and Mesnil
[5] brieﬂy survey the observations concerning this speciﬁc localiza-
tion of connexins in lipid rafts and its consequences on gap junctional
intercellular communication capacity, with a particular interest on
the role of the lipid raft–connexin connection in cancer progression.
Gap junctional proteins, as other integral plasma membrane pro-
teins (other channels, other intercellular junctions, or various mem-
brane receptors) are usually renewed several times a day. Therefore,
endocytosis and post-endocytic trafﬁcking of junctional proteins de-
termine the amount of functional gap junctions at the plasma mem-
brane. There is increasing evidence showing that multiple pathways
exist for endocytosis and sorting of connexins to lysosomes, and
that these pathways are differentially regulated (notably through a
complex interplay between phosphorylation and ubiquitination) in
response to physiological and pathophysiological stimuli. Leithe,
Sirnes, Fykerud, Kjenseth, and Rivedal [6] overview recent progress
in understanding the molecular mechanisms involved in endocytosis
and post-endocytic sorting of connexins.
1804 EditorialHemichannels dispersed in nonjunctional membranes were for a
long time considered to remain permanently closed to avoid cell
death but several data have documented that innexins, connexins,
and pannexins can all form “hemichannels” able to open with a ﬁnite
low probability. As pannexins and connexins have largely overlapping
distributions in vertebrate tissues, the molecular identity of the pro-
tein that performs the function of hemichannels inmammalian tissues
is still debated. Scemes [7] highlights evidences and controversies re-
lated to the respective assignments of connexin hemichannels and
pannexin channels as being the functional “hemichannels”.
The ﬁrst physiological function associated with gap junction chan-
nels is their unique ability to mediate the direct exchange of ions and
small metabolites between cells. These channels were originally
viewed as large, non-speciﬁc pores connecting cells but the diversity
in the connexin family rapidly led attention on their permeability
characteristics. Cells in many tissues co-express several gap junction
protein isoforms, and distinct connexins or innexins may form hybrid
or “heterotypic” cell–cell channels. Palacios-Prado and Bukauskas [8]
present the gating and permeability properties of Cx43/Cx45 hetero-
typic intercellular channels and the resulting modulation of cell-to-
cell transfer of metabolites and signalling molecules by trans-
junctional voltage.
Communicating junctions play crucial roles in the maintenance of
homeostasis, morphogenesis, cell differentiation, and growth control
in metazoans. Nitric oxide signalling is involved in many physiologi-
cal and pathological processes, particularly as a powerful endogenous
vasorelaxant. NO modulates the activities of several membrane chan-
nels, including connexin and pannexin-built channels through differ-
ent mechanisms (e.g. S-direct nitrosylation). Looft-Wilson, Billaud,
Johnstone, Straub and Isakson [9] examine the interrelationship be-
tween endothelial nitric oxide synthase/nitric oxide signalling and
connexin function in normal and diseased arteries, with resulting en-
hancement or inhibition of junctional communication, depending on
the involved connexin and the cellular location within the vessel.
The intercellular communication in the vasculature contributes to
the regulation of resistance in different vascular beds and therefore
ultimately participates in the regulation of blood pressure. Kurtz
[10] explains how the different renal connexins present within both
the vasculature and the tubular system may inﬂuence blood pressure
by both an efﬁcient control of preglomerular vascular tone and a reg-
ulation of renin secretion. Moreover, a calcium-induced secretion of
ATP and UTP through hemichannels may also lead to stimulation of
purinergic receptors on neighbouring cells, giving rise to a propagat-
ed calcium wave.
The skeleton is a dynamic system which, after full development
(bone modelling), is constantly remodelled to preserve structural in-
tegrity, mechanical competence as well as mineral homeostasis and
to respond to a large number of stimuli, including calcitropic hor-
mones, growth factors and mechanical load. The control of bone
modelling and remodelling requires a ﬁnely orchestrated interplay
among bone forming cells (osteoblasts), bone resorbing cells (osteo-
clasts) and cells embedded in bone (osteocytes). Batra, Kar and
Jiang [11] summarise the recent ﬁndings regarding the roles of gap
junctions and hemichannels in regulating the passage of molecules
through bone cells, intercellular signalling events, osteoblast differen-
tiation, mechanotransduction and overall bone development.
Most endocrine and exocrine secretions are multicellular events
which depend on the coordinated activity of numerous individual
cells. To achieve such coordination, secretory cells cross-talk through
various ways which, with evolution, have been progressively inte-
grated into a complex regulatory network that allows individual en-
docrine and neuro-endocrine cells to sense the state of activity oftheir neighbours and to regulate, accordingly, their own activity.
Such coordination is essential to provide the integrated functioning
of the system as a whole, and to permit its dynamic adaptation to
continuous internal and environmental changes. Potolicchio, Cigliola,
Velazquez-Garcia, Klee, Valjevac, Kapic, Cosovic, Lepara, Hadzovic-
Dzuvo, Mornjacovic and Meda [12] overview the distribution of con-
nexins in the mammalian (neuro)endocrine systems, and what is
known concerning the participation of these proteins on hormone se-
cretion, on the life of the producing cells, and on the action of (neuro)
hormones on speciﬁc targets. The adrenal medullary tissue contrib-
utes to maintain body homeostasis in reaction to stressful environ-
mental changes via the release of catecholamines into the blood
circulation in response to splanchnic nerve activation, but the regula-
tory mechanisms underlying synaptogenic progression from electri-
cal to chemical neurotransmission still remain poorly understood.
Colomer, Martin, Desarménien and Guérineau [13] show how gap
junctions, allowing cell–cell propagation of electrical and ensuing cal-
cium signals, are ideal candidates to complement the incoming ner-
vous command and to coordinate, enhance or limit catecholamine
secretion from chromafﬁn cells.
The skin, which provides an effective barrier between the organ-
ism and the environment, consists of two distinct tissues, dermis
and epidermis. The epidermis is primarily composed of keratinocytes
that are subdivided into four layers. At least nine connexin genes
were shown to be expressed during the keratinocyte differentiation
process, with distinct spatial and temporal expression patterns as
well as some overlapping tissue distribution during embryological
development and epithelial differentiation. Scott, Tattersall, O'Toole
and Kelsell [14] summarise what is known about the role of Cxs in
epidermal barrier homeostasis, wound healing and the association
of Cx gene mutations with skin disease.
Cardiac muscle is composed of individual cells each invested with
an insulating lipid bilayer. As a result, electrical activation of the myo-
cardium requires intercellular transfer of current through gap junction
channels, enabling physiological synchronized contraction of the atria
and ventricles. In addition, connexin hemichannels and pannexin
channels also allow communication between the cytosol and the ex-
tracellular space, thus enabling a completely different communication
system, involving activation of extracellular receptors. Rodríguez-
Sinovas, Sánchez, Fernandez-Sanz, Ruiz-Meana and García-Dorado
[15] discuss the roles played by both connexin hemichannels and pan-
nexin channels in cell communication, with special emphasis on their
roles in cell injury.
In humans, 21 different connexin genes have been identiﬁed, 20 in
mouse, and a similar diversity exists in invertebrates. It remains
unclear why such a large number of gap junction proteins are re-
quired to provide this universal type of intercellular communication,
used by virtually all cells that are in direct contact. Moreover, most
cell types express several connexin or innexin isotypes, lending sup-
port to the view that redundancy and compensation among family
members exist, but functional replacement of one channel gene
with another in mice and ﬂies revealed that cellular health depends
not simply on gap junction communication but also requires the
proper type of intercellular channel subunit. Bedner, Steinhäuser
and Theis [16] overview the current knowledge on redundancy and
functional compensation (or lack thereof) among members of gap
junction protein families.
Phosphorylation is the most common and abundant post-
translational modiﬁcation to eukaryotic proteins, regulating a pletho-
ra of dynamic cellular processes. Most connexins are known to be
phosphorylated by protein kinases that lead to modiﬁcations in tyro-
sine, serine, and threonine residues which have been implicated in
1805Editorialthe regulation of gap junctional communication at several stages of
the connexin “life cycle”, including hemichannel oligomerization, ex-
port of the protein to the plasma membrane, hemichannel activity,
gap junction assembly, gap junction channel gating and connexin deg-
radation.Márquez-Rosado, Solan, Dunn,Norris and Lampe [17] focused
on the use of recently developed phosphospeciﬁc antibodies to Cx43 to
begin to correlate in situ speciﬁc phosphorylation events with changes
in cell and tissue function. Alterations in the phosphorylation status of
the connexins result in functional alteration of cell–cell junctional com-
munication. It is for example the case in the involvement of Cx43 in the
development of an injury-resistant phenotype in cells, particularly
cardiomyocytes. Preconditioning is an adaptive cellular response to
noxious exposures, where sub-threshold injury activates endogenous
protective mechanisms that increase cellular resistance to subsequent
more severe injury. Jeyaraman, Srisakuldee, Nickel and Kardami [18]
provide an overview of the emerging recognition of a relationship be-
tween Cx43, its phosphorylation pattern, and development of resis-
tance to injury.
Extensively studied and well-appreciated functions of gap junc-
tion proteins relate to their channel and hemichannel forming ability,
but non-channel-dependent activities of these proteins are also be-
coming increasingly appreciated and include effects on growth sup-
pression, gene expression, cell migration and cell survival. Cell
migration is a fundamental process playing key roles during embryo-
genesis but also involved in many physiological functions of the adult
organism (as immune surveillance, angiogenesis or wound healing)
as well as in pathophysiological processes (e.g. tumour growth, me-
tastasis or vascular remodelling in atherosclerosis). Kameritsch,
Pogoda and Pohl [19] summarise the current knowledge about the
role of connexins, particularly Cx43, in the control of cell migration,
with special reference to channel-independent mechanisms and the
importance of the carboxyl tail of Cx43. Vinken, Decrock, Leybaert,
Bultynck, Himpens, Vanhaecke and Rogiers [20] examine the involve-
ment of non-channel functions of gap junction proteins in cell growth
and cell death control via two main mechanisms, namely the modula-
tion of the expression of tissue homeostasis gatekeepers and the in-
teraction with cell growth and cell death regulators.
Hemichannels may represent an important diffusional exchange
pathway with the extracellular space but the extent of their normal
physiological role is currently unknown. Aberrant hemichannel ac-
tivity has been linked to mutations of connexin proteins involved in
genetic diseases. The most common connexin-related disease is ge-
netic deafness, frequently associated with skin disorders and other ec-
todermal abnormalities. Mutations affecting Cx26 are one of the most
common (more than 100 mutations have already been identiﬁed,
scattered throughout the Cx26 protein). Levit, Mese, Basaly and White
[21] review a proposed role for hemichannels in the pathogenesis of
Keratitis-Ichthyosis-Deafness (KID) syndrome associated with Cx26
mutations. If connexin mutations have very rarely been identiﬁed as a
cause of human cardiac disease, remodelling of connexin expression
and gap junction organization is well documented in acquired adult
heart disease. Remodelling may take the form of alterations in the distri-
bution of gap junctions or in the amount and type of connexins expressed.
Fontes, van Veen, de Bakker and van Rijen [22] focus on the remodelling
of Cx43, themajor cardiac connexin, in hypertrophic, dilated and ischemic
cardiomyopathies together with its functional consequences of conduc-
tion velocity slowing, dispersed impulse conduction, its interaction with
ﬁbrosis and propensity to generate arrthythmias.
Gap junction proteins, widely expressed in the various cell types of
both central nervous system and peripheral nervous system, are in-
volved in a plethora of functions, including intercellular signalling
(propagation of action potentials and of Ca2+ waves), metabolicsupport (e.g. the dispersion of K+ taken up by the astrocyte after neu-
ronal activity), and normal myelinisation. In the central nervous sys-
tem, neurons and glial cells (astrocytes, oligodendrocytes, and
microglia) represent the two main cell populations. Mutations in at
least 10 of connexin genes cause human diseases; Abrams and Scherer
[23] focus their attention on three of them (Cx32, Cx43 and Cx47) hav-
ing signiﬁcant central nervous system manifestations and emphasize
the clinical phenotypes and current understanding of the pathogene-
sis of these genetic diseases. Koulakoff, Mei, Orellana, Sáez and
Giaume [24] summarise the current knowledge on connexin expres-
sion and function in astrocytes and microglial cells, the two cell
types involved in “reactive gliosis”, a proliferation of astrocytes in
damaged areas leading to the formation of a glial scar. A special atten-
tion is devoted to Alzheimer's disease, where recent in vitro and in
vivo data indicate that connexins and possibly pannexins might con-
tribute in the neurodegenerative process encountered during progres-
sion of the disease. Gap junctional communication is involved in the
regulation of cell homeostasis, proliferation, and differentiation but
accumulated evidence also indicates that connexins may function as
tumour suppressor genes. Many tumour promoting agents, onco-
genes, and growth factors inhibit junctional communication whereas
antineoplastic agents (e.g. retinoids, vitamin D or carotenoids) up-
regulate it. Sin, Crespin and Mesnil [25] discuss how Cx43 appears to
be involved at different levels of progression of the glioma (the most
common and most aggressive malignant primary brain tumour in
humans, involving glial cells) by acting on cell growth regulation, pro-
motion of cell migration and resistance to apoptosis.
Skin lesions need rapid healing to maintain homeostasis and pre-
vent infection and sepsis. The wound healing is a synchronized and
ﬁnely coordinated interplay of several cellular components (ﬁbroblasts,
myoﬁbroblasts, smooth muscle cells, endothelial cells, keratinocytes
and immune cells), mediated by numerous factors (growth factors,
hormones, blood components and second messengers). In case of dia-
betes, this synchronization is interrupted due to several extrinsic
(high glucose level, oxidative stress) and intrinsic (cytokines, pro-
apoptotic and anti-apoptotic molecules) factors, which in turn result
in delayed wound healing. In recent years, connexins have been
found to play a pivotal role in a variety of aspects of the acute wound
healing process. Becker, Thrasivoulou and Phillips [26] explain how it
is possible, by manipulating them in different ways, to accelerate and
improve the normal healing process.
Small interfering RNA (siRNA), a class of double-stranded RNA
molecules, 20–25 nucleotides in length, able to profoundly affect
gene expression, carries great potential therapeutic applications,
based on the highly speciﬁc and efﬁcient silencing of a target gene.
Unfortunately, successful gene therapy by siRNAs depends on the
development of efﬁcient delivery systems, siRNAs being too large,
too charged, and too rigid to passively diffuse across the cellular
membrane. Brink, Valiunas, Gordon, Rosen, and Cohen [27] discuss
the advantages and disadvantages of extracellular delivery, utilizing
pinocytotic delivery of exosomes, and cell to cell delivery, from a
source cell to a recipient cell, through Cx43 gap junction channels.
Tunnelling nanotubes are recently discovered conduits for a pre-
viously unrecognized form of cell-to-cell communication. These
long and thin tubes (50–200 nm in diameter) formed from the plas-
ma membrane that connect different animal cells, establishing de
novo between them up to a distance of several cell diameters. They
permit the direct intercellular transfer of not only cytoplasmic mol-
ecules, vesicles, organelles and membrane components but also of
pathogens (as prions or human immunodeﬁciency virus). Wang
and Gerdes [28] summarise their functions, particularly the transfer
of electrical signals between remote cells through gap junction
1806 Editorialchannels interposed at themembrane interface between the tunnel-
ling nanotube and the connected cell, and discuss potential physio-
logical implications of this long range signalling.
I wish to thank all the authors and co-authors for their commit-
ments and the anonymous reviewers who contributed by their con-
structive remarks to the excellence of this issue.References
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